Hemoglobin Screening Recommendations for Pediatric Patients

Universal Screening for High‑Risk Infants

The CDC recommends that all infants from high‑risk groups (e.g., low‑income families, children eligible for nutrition assistance programs, recent refugees, or migrants) receive a first hemoglobin screen between 9 – 12 months of age【1】【2】【3】.
A second screen should be performed ≈ 6 months later (at 15 – 18 months) to capture later‑developing iron deficiency【1】【2】.
Children who remain high‑risk should undergo annual screening from 2 – 5 years of age【1】【2】【3】.

The American Academy of Pediatrics (2016) confirms universal hemoglobin screening at 12 months to detect iron‑deficiency anemia, with a risk‑based assessment at 15 months and again at 30 months to decide on additional testing【4】.

For infants not classified as high‑risk, the CDC advises screening only if specific risk factors are present at 9 – 12 months and a repeat screen at 15 – 18 months【1】【2】【3】.
Documented risk factors include:

The CDC recommends screening before 6 months for preterm or low‑birth‑weight infants not receiving iron‑fortified formula, reflecting their heightened vulnerability to iron depletion【1】【2】【5】.

An annual risk assessment is required for children aged 2‑5 years; hemoglobin testing is performed only when risk factors such as a low‑iron diet, limited food access due to poverty or neglect, or special health‑care needs are identified【1】【2】【3】.

The CDC advises selective screening for school‑age children and adolescent boys only if they have:

Delaying the first screen until 12 months for high‑risk infants is a frequent error; the CDC emphasizes screening as early as 9 months【1】【2】【3】.
Missing the follow‑up screen at 15‑18 months can overlook children who develop iron deficiency after the initial test; the AAP highlights this gap【4】.
Failing to screen preterm/low‑birth‑weight infants before 6 months deprives a high‑risk group of early detection, potentially leading to developmental consequences【1】【5】.